相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted protein degraders crowd into the clinic
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Maintenance of organellar protein homeostasis by ER-associated degradation and related mechanisms
Marius K. Lemberg et al.
MOLECULAR CELL (2021)
Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe et al.
CELL CHEMICAL BIOLOGY (2021)
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond et al.
RSC CHEMICAL BIOLOGY (2021)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
Nur Najmi Mohamad Anuar et al.
FRONTIERS IN PHARMACOLOGY (2020)
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2020)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Cellular quality control by the ubiquitin-proteasome system and autophagy
Christian Pohl et al.
SCIENCE (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Phosphorylation of Human TFAM in Mitochondria Impairs DNA Binding and Promotes Degradation by the AAA+ Lon Protease
Bin Lu et al.
MOLECULAR CELL (2013)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
